Cosmos Health Inc. (COSM)
0.35
-0.00 (-0.11%)
At close: Apr 07, 2025, 3:59 PM
0.36
3.01%
After-hours: Apr 07, 2025, 04:43 PM EDT
Company Description
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company.
It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace.
The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility.
It serves wholesale pharmaceutical distributors and independent retail pharmacies.
Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Cosmos Health Inc.

Country | United States |
IPO Date | Jul 23, 2010 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 123 |
CEO | Grigorios Siokas |
Contact Details
Address: 141 West Jackson Boulevard Chicago, Illinois United States | |
Website | https://www.cosmosholdingsinc.com |
Stock Details
Ticker Symbol | COSM |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001474167 |
CUSIP Number | 221413206 |
ISIN Number | US2214133058 |
Employer ID | 27-0611758 |
SIC Code | 5122 |
Key Executives
Name | Position |
---|---|
Grigorios Siokas | Chairman & Chief Executive Officer |
Georgios Terzis | Chief Financial Officer |
Nikolaos Bardakis | Chief Operating Officer |
Demetrios G. Demetriades | Secretary & Independent Director |
Prof. Dimitrios Trafalis | Head of Oncology |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 04, 2025 | 3 | Filing |
Mar 31, 2025 | NT 10-K | Filing |
Mar 06, 2025 | SCHEDULE 13G | Filing |
Mar 05, 2025 | 4 | Filing |
Mar 04, 2025 | 4 | Filing |
Feb 28, 2025 | SCHEDULE 13D/A | [Amend] Filing |
Feb 25, 2025 | 4 | Filing |
Feb 18, 2025 | 8-K | Current Report |
Feb 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Feb 14, 2025 | 5 | Filing |